SELLAS Life Sciences Group, Inc. (SLS)
Track the next or latest earnings date for SELLAS Life Sciences Group, Inc. , review consensus estimates, and see cached AI analysis for recent quarterly results.
Recent earnings news
stocktwits.com · 1 day ago
First Financial Bank also held 10,000 SLS shares, valued at $147,600.
SLS Stock Rises Overnight: Why Retail Traders Prefer Sellas Over IBRX, ONDS, PYPL As Most Bullish Pickstocktwits.com · 3 hours ago
Traders are watching for the 80th event, data lock and topline results, while some are also speculating about potential M&A.
SLS Stock Logs Record H1 As AML Trial Nears Finish Line — Why Are Retail Traders Refusing To Cash Out?stocktwits.com · 1 week ago
Buyout chatter is building after change-of-control updates and a market-cap surge to over $1.5 billion.
This Little-Known Stock Has Surged 550% in the Past Yearfinance.yahoo.com · 16 hours ago
SELLAS Life Sciences (SLS) has surged 550% in the past year, driven by technical momentum and speculative trading. SLS currently has no revenue, with all products in development or clinical trials, making the stock highly speculative. Technical indicators are overwhelmingly bullish, but high ...
SLS Stock Sees Worst Day In Over A Month — But Prediction Market Flashes 83% Odds For November AML Trial Successfinance.yahoo.com · 5 days ago
Endpoint Area listed Nov. 30 as the expected catalyst timing for Sellas’ Phase 3 GPS trial.
Latest earnings date
Time not specified
Fiscal quarter: 2025-12-31
EPS estimate: N/A
Revenue estimate: N/A
Market cap: $2.79B
Analysis snapshot
No cached AI earnings analysis is available for this stock yet. Check back after the company reports or open the app to generate a fresh analysis.
Recent earnings history
Browse the calendar week| Date | Quarter | Report window | EPS est. | Revenue est. |
|---|---|---|---|---|
| Mar 19, 2026 | 2025-12-31 | Time not specified | N/A | N/A |